Clinical Trial Update: Second-line Chemotherapy in Castration Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial testing second-line chemotherapy for metastatic castration-resistant prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: Tampere University Hospital | Conditions: Metastatic Prostate Cancer | Phase 2 | Status: COMPLETED